Quidel Completes Acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses
16 mai 2017 17h15 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - May 16, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Receives FDA Clearance for Its New Solana(R) Molecular Assay for the Detection of Clostridium difficile (C. difficile) Infections
11 mai 2017 14h30 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - May 11, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
01 mai 2017 17h30 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - May 01, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Reports First Quarter 2017 Financial Results
24 avr. 2017 16h10 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - April 24, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel to Hold First Quarter 2017 Financial Results Conference Call on April 24, 2017
11 avr. 2017 19h00 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - April 11, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel to Present at the Barclays Global Healthcare Conference
02 mars 2017 18h00 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - March 02, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Reports Fourth Quarter and Full Year 2016 Financial Results
08 févr. 2017 16h10 HE
|
Quidel
SAN DIEGO, CA --(Marketwired - February 08, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic...
Quidel to Hold Fourth Quarter and Full Year 2016 Financial Results Conference Call on February 8, 2017
25 janv. 2017 16h30 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - January 25, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Announces Modification of Revenue Reporting Categories
23 janv. 2017 19h00 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - January 23, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Announces Preliminary Revenue for Fourth Quarter 2016
06 janv. 2017 16h10 HE
|
Quidel
SAN DIEGO, CA--(Marketwired - January 06, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...